In this study, supplementation of MN-Gup-GOS-XOS increased the levels of PYY, CCK, and OXM in individuals with obesity, which provided a possible explanation for the mechanism of MN-Gup-GOS-XOS reducing LDL-C. Here, PYY is linked to obesity due to melanocortin 4 receptor deficiency.